Table 6.
Heterogeneity for the total sample (HMC and SC)
| Group | Number studies | Heterogeneity | |||
|---|---|---|---|---|---|
| Q‐value | df (Q) | p‐value | τ‐squared | ||
| Fixed effect analysis | |||||
| Age: <14 | 2 | 0.029 | 1 | .866 | 0.000 |
| Autosomal Recessive | 2 | 2.923 | 1 | .087 | 0.222 |
| Autosomal Dominant | 1 | 0.000 | 0 | 1.000 | 0.000 |
| Chromosomal | 2 | 2.599 | 1 | .107 | 0.659 |
| Gender: Male | 2 | 0.004 | 1 | .949 | 0.000 |
| Undiagnosed | 2 | 0.652 | 1 | .419 | 0.000 |
| X‐linked | 2 | 0.519 | 1 | .471 | 0.000 |
| Total within | 6.725 | 6 | .347 | ||
| Total between | 15.162 | 6 | .019 | ||
| Overall | 13 | 21.887 | 12 | .039 | 0.086 |
Abbreviation: HMC, Hamad Medical Corporation; SC, Shafallah Center.